Jefferies Reiterates Hold Rating on Medpace (MEDP)

September 14, 2026 5:57 AM

Jefferies analyst David Windley reiterated a Hold rating and $560.00 price target on Medpace (NASDAQ: MEDP).The analyst comments "Our HQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found